Table 1. Clinical data for study sample.
| Complete sample | SDC sample | Inter99 cohort | |
| N (m/w) | 9438 (4834/4604) | 2924 (1665/1259) | 6514 (3169/3345) |
| NGT | 5302 (2456/2846) | 734 (334/400) | 4568 (2122/2446) |
| IFG | 540 (391/149) | 32 (18/14) | 508 (373/135) |
| IGT | 830 (414/416) | 123 (66/57) | 707 (348/359) |
| SDU DM | 294 (187/107) | 39 (27/12) | 255 (160/95) |
| Known DM | 2051 (1259/801) | 1946 (1200/755) | 105 (59/46) |
| NGT age (years) | 47±9 | 58±9 | 45±8 |
| NGT BMI (kg/m2) | 25.6±9.1 | 25.9±8.7 | 25.5±4.1 |
| T2D age (years) | 60±12 | 62±11 | 51±7 |
| T2D BMI (kg/m2) | 30.1±5.5 | 30.0±5.5 | 30.4±5.6 |
| T2D HbA1c (%) | 7.8±1.7 | 8.1±1.6 | 7.1±1.7 |
Data is mean±S.D. SDC, Steno Diabetes Center; N (m/w), number (men/women); NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; SDU DM, screen detected untreated diabetes mellitus; T2D, Type 2 diabetes; BMI, Body Mass Index; HbA1c, hemoglobin A1c.